COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 23:05, il y a 1 année 11 mois De Oro Devices Names Cori Lathan, PhD, as New CEO Dr. Cori Lathan has been appointed as the new Chief Executive Officer of De Oro Devices, and she brings over 20 years of experience in medical technology to drive the health tech startup forward. With her expertise in brain health, age tech, and mobility products, Dr. Lathan is poised to lead De Oro Devices to new heights of growth and innovation in the healthcare industry. De Oro Devices Dr. Cori Lathan Medical Technology Health Tech Startup Mobility Impairment
Publié le 19/12/2025 à 08:30, il y a 7 heures 37 minutes Share capital decrease by way of treasury shares cancellation
Publié le 19/12/2025 à 08:30, il y a 7 heures 37 minutes Réduction du capital par voie d’annulation d’actions propres
Publié le 19/12/2025 à 07:00, il y a 9 heures 7 minutes EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Publié le 19/12/2025 à 07:00, il y a 9 heures 7 minutes EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Publié le 18/12/2025 à 18:30, il y a 21 heures 37 minutes Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Publié le 19/12/2025 à 14:40, il y a 1 heure 27 minutes Northern Superior Announces Closing of the Arrangement
Publié le 19/12/2025 à 13:30, il y a 2 heures 37 minutes Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Publié le 19/12/2025 à 13:30, il y a 2 heures 37 minutes DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Publié le 19/12/2025 à 13:30, il y a 2 heures 37 minutes Sterling Metals Provides Year End Update to Stakeholders
Publié le 19/12/2025 à 13:05, il y a 3 heures 2 minutes Roxmore Resources Begins Trading on the OTCQX Best Market in the United States
Publié le 19/12/2025 à 14:54, il y a 1 heure 12 minutes Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Publié le 19/12/2025 à 14:51, il y a 1 heure 15 minutes Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc